Back
ESCO Technologies 10K Form
Buy
52
ESE
ESCO Technologies
Last Price:
128.25
Seasonality Move:
9.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-10 | 10Q | ESE/ESCO Technologies Quarterly |
2024-02-09 | 10Q | ESE/ESCO Technologies Quarterly |
2023-08-09 | 10Q | ESE/ESCO Technologies Quarterly |
2023-05-10 | 10Q | ESE/ESCO Technologies Quarterly |
2023-02-09 | 10Q | ESE/ESCO Technologies Quarterly |
2022-08-09 | 10Q | ESE/ESCO Technologies Quarterly |
Receive ESE News And Ratings
See the #1 stock for the next 7 days that we like better than ESE
ESE Financial Statistics
Sales & Book Value
Annual Sales: | $956.03M |
---|---|
Cash Flow: | $24.93M |
Price / Cash Flow: | 54.21 |
Annual Sales: | $46.35 |
Price / Book: | 2.77 |
Profitability
EPS (TTM): | 3.86000 |
---|---|
Net Income (TTM): | $99.62M |
Gross Margin: | $375.66M |
Return on Equity: | 8.66% |
Return on Assets: | 5.69% |
ESCO Technologies Earnings Forecast
Key ESCO Technologies Financial Ratios
- The Gross Profit Margin over the past 34 years for ESE is 39.29%.
- The Selling, General & Administrative Expenses for ESE have been equal to 22.71% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 9.48% of Operating Income.
- The Net Earning history of ESE is 9.68% of Total Revenues.
- Per Share Earnings over the last 34 years have been positive in 20 years.
ESCO Technologies Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Machinery |
Sector: | Industrials |
Current Symbol: | ESE |
CUSIP: | 296315 |
Website: | escotechnologies.com |
Debt
Debt-to-Equity Ratio: | 0.14 |
---|---|
Current Ratio: | 2.1 |
Quick Ratio: | 1.32 |
Price-to-Earnings
Trailing P/E Ratio: | 35.81 |
---|---|
Forward P/E Ratio: | 23.54 |
ESE Technical Analysis vs Fundamental Analysis
Buy
52
ESCO Technologies (ESE)
is a Buy
Is ESCO Technologies a Buy or a Sell?
-
ESCO Technologies stock is rated a Buy
The current ESCO Technologies [ESE] share price is $128.21. The Score for ESE is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.